{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T22:22:03Z","timestamp":1767565323097,"version":"3.48.0"},"reference-count":29,"publisher":"CSIRO Publishing","issue":"1","license":[{"start":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T00:00:00Z","timestamp":1767484800000},"content-version":"vor","delay-in-days":4055,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11,28]]},"abstract":"<jats:p>Creutzfeldt\u2013Jakob disease (CJD) is a fatal disease caused by the accumulation of abnormal prion proteins in neurological tissues. Routine notification data reveal that NSW has similar rates of CJD to other states and territories in Australia; however, it is likely that there is significant under-ascertainment of cases. It is important that clinicians and public health staff remain vigilant for the clinical signs of CJD and understand the limitations of the different diagnostic tests available. This paper provides a brief overview of the epidemiology of CJD in NSW, as well as current issues in the diagnosis and public health investigation of CJD.<\/jats:p>","DOI":"10.17061\/phrp2511409","type":"journal-article","created":{"date-parts":[[2014,11,23]],"date-time":"2014-11-23T19:51:00Z","timestamp":1416772260000},"source":"Crossref","is-referenced-by-count":1,"title":["An update on the epidemiology and key issues associated with the diagnosis and management of Creutzfeldt\u2013Jakob disease cases in NSW"],"prefix":"10.1071","volume":"25","author":[{"given":"Emma","family":"Quinn","sequence":"first","affiliation":[{"name":"a NSW Public Health Officer Training Program, NSW Ministry of Health, Sydney, Australia"},{"name":"b School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia"},{"name":"c Communicable Diseases Branch, Health Protection NSW, NSW Health, Sydney, Australia"},{"name":"f Corresponding author: equin@doh.health.nsw.gov.au"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony","family":"Merritt","sequence":"additional","affiliation":[{"name":"d Communicable Diseases Team, Health Protection, Hunter New England Population Health, Newcastle, NSW, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E","family":"Buckland","sequence":"additional","affiliation":[{"name":"e Neuropathology Department, Royal Prince Alfred Hospital, and Brain and Mind Research Institute, University of Sydney, NSW, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Tobin","sequence":"additional","affiliation":[{"name":"c Communicable Diseases Branch, Health Protection NSW, NSW Health, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"67","published-online":{"date-parts":[[2014,11,28]]},"reference":[{"key":"2026010417165218900_R1","doi-asserted-by":"crossref","unstructured":"Imran M, Mahmood S. An overview of human prion diseases. Virol J. 2011;8:559. Epub 2011 Dec 27. CrossRef | PubMed","DOI":"10.1186\/1743-422X-8-559"},{"key":"2026010417165218900_R2","doi-asserted-by":"crossref","unstructured":"Puoti G, Bizzi A, Forloni G, Safar JG, Tagliavini F, Gambetti P. Sporadic human prion diseases: molecular insights and diagnosis. Lancet Neurol. 2012;11(7):618\u201328. Epub 2012 Jun 20. CrossRef | PubMed","DOI":"10.1016\/S1474-4422(12)70063-7"},{"key":"2026010417165218900_R3","doi-asserted-by":"crossref","unstructured":"Wadsworth JD, Collinge J. Molecular pathology of human prion disease. Acta Neuropathol. 2011;121(1):69\u201377. Epub 2010 Aug 10. CrossRef | PubMed","DOI":"10.1007\/s00401-010-0735-5"},{"key":"2026010417165218900_R4","doi-asserted-by":"crossref","unstructured":"Gambetti P, Cali I, Notari S, Kong Q, Zou WQ, Surewicz WK. Molecular biology and pathology of prion strains in sporadic human prion diseases. Acta Neuropathol. 2011;121(1):79\u201390. Epub 2010 Nov 09. CrossRef | PubMed","DOI":"10.1007\/s00401-010-0761-3"},{"key":"2026010417165218900_R5","doi-asserted-by":"crossref","unstructured":"Aguzzi A, Heikenwalder M. Pathogenesis of prion diseases: current status and future outlook. Nat Rev Microbiol. 2006;4(10):765\u201375. Epub 2006 Sep 19. CrossRef | PubMed","DOI":"10.1038\/nrmicro1492"},{"key":"2026010417165218900_R6","unstructured":"Allars M. Report of the inquiry into the use of pituitary derived hormones in Australia and Creutzfeldt-Jakob Disease. Canberra: Australian Government Publishing Service; 1994"},{"key":"2026010417165218900_R7","doi-asserted-by":"crossref","unstructured":"Klug GM, Boyd A, McGlade A. Surveillance of Creutzfeld-Jakob disease in Australia: update to December 2012. Commun Dis Intell. 2013;37(2):E115\u2013E20.","DOI":"10.33321\/cdi.2013.37.16"},{"key":"2026010417165218900_R8","doi-asserted-by":"crossref","unstructured":"Ladogana A, Puopolo M, Croes EA, Budka H, Jarius C, Collins S, et al. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology. 2005;64(9):1586\u201391. Epub 2005 May 11. CrossRef | PubMed","DOI":"10.1212\/01.WNL.0000160117.56690.B2"},{"key":"2026010417165218900_R9","unstructured":"NSW Ministry of Health. Creutzfeld-Jakob disease: control guideline for public health units. Sydney: Communicable Diseases Branch, NSW Department of Health; 2004."},{"key":"2026010417165218900_R10","doi-asserted-by":"crossref","unstructured":"Klug GM, Boyd, A, McGlade,et al. Surveillance of Creutzfeld-Jakob disease in Australia: update to December 2011. Commun Dis Intell. 2012;36(2):E174\u2013E9.","DOI":"10.33321\/cdi.2012.36.12"},{"key":"2026010417165218900_R11","unstructured":"World Health Organization. Variant Creutzfeldt\u2013Jacob disease. Fact sheet 180. Geneva: World Health Organization; 2012 [cited 2014 Sep 4]. Available from: https:\/\/www.who.int\/mediacentre\/factsheets\/fs180\/en\/"},{"key":"2026010417165218900_R12","doi-asserted-by":"crossref","unstructured":"Klug GM, Wand H, Boyd A, Law M, Whyte S, Kaldor J, et al. Enhanced geographically restricted surveillance simulates sporadic Creutzfeldt-Jakob disease cluster. Brain. 2009;132(Pt 2):493\u2013501. Epub 2008 Dec 02. PubMed","DOI":"10.1093\/brain\/awn303"},{"key":"2026010417165218900_R13","doi-asserted-by":"crossref","unstructured":"Gelpi E, Heinzl H, Hoftberger R, Unterberger U, Strobel T, Voigtlander T, et al. Creutzfeldt-Jakob disease in Austria: an autopsy-controlled study. Neuroepidemiology. 2008;30(4):215\u201321. Epub 2008 Apr 22. CrossRef | PubMed","DOI":"10.1159\/000126915"},{"key":"2026010417165218900_R14","doi-asserted-by":"crossref","unstructured":"Klug GM, Wand H, Simpson M, Boyd A, Law M, Masters CL, et al. Intensity of human prion disease surveillance predicts observed disease incidence. J Neurol, Neurosur PS. 2013:84:12(1372\u20131377). Epub 2013 Aug 24. PubMed | Full text","DOI":"10.1136\/jnnp-2012-304820"},{"key":"2026010417165218900_R15","doi-asserted-by":"crossref","unstructured":"Meissner B, Kallenberg K, Sanchez-Juan P, Collie D, Summers DM, Almonti S, et al. MRI lesion profiles in sporadic Creutzfeldt-Jakob disease. Neurology. 2009;72(23):1994\u20132001. Epub 2009 Jun10. CrossRef | PubMed","DOI":"10.1212\/WNL.0b013e3181a96e5d"},{"key":"2026010417165218900_R16","doi-asserted-by":"crossref","unstructured":"Wieser HG, Schindler K, Zumsteg D. EEG in Creutzfeldt-Jakob disease. Clin Neurophysiol. 2006;117(5):935\u201351. Epub 2006 Jan 31. CrossRef | PubMed","DOI":"10.1016\/j.clinph.2005.12.007"},{"key":"2026010417165218900_R17","doi-asserted-by":"crossref","unstructured":"Muayqil T, Gronseth G, Camicioli R. Evidence-based guideline: diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease: report of the guideline development subcommittee of the American Academy of Neurology. Neurology. 2012;79(14):1499\u2013506. Epub 2012 Sep 21. CrossRef | PubMed","DOI":"10.1212\/WNL.0b013e31826d5fc3"},{"key":"2026010417165218900_R18","doi-asserted-by":"crossref","unstructured":"Collins SJ, Sanchez-Juan P, Masters CL, Klug GM, van Duijn C, Poleggi A, et al. Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain. 2006;129(Pt 9):2278\u201387. Epub 2006 Jul 04. CrossRef | PubMed","DOI":"10.1093\/brain\/awl159"},{"key":"2026010417165218900_R19","doi-asserted-by":"crossref","unstructured":"Tschampa HJ, Kallenberg K, Urbach H, Meissner B, Nicolay C, Kretzschmar HA, et al. MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease: a study on inter-observer agreement. Brain. 2005;128(Pt 9):2026\u201333. Epub 2005 Jun 17. CrossRef | PubMed","DOI":"10.1093\/brain\/awh575"},{"key":"2026010417165218900_R20","doi-asserted-by":"crossref","unstructured":"Windl O, Dempster M, Estibeiro JP, Lathe R, de Silva R, Esmonde T, et al. Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene. Hum genet. 1996;98(3):259\u201364. Epub 1996 Sep 1. CrossRef | PubMed","DOI":"10.1007\/s004390050204"},{"key":"2026010417165218900_R21","doi-asserted-by":"crossref","unstructured":"Lloyd SE, Mead S, Collinge J. Genetics of prion diseases. Curr Opin Genet Dev. 2013;23(3):345\u201351. Epub 2013 Mar 23. CrossRef | PubMed","DOI":"10.1016\/j.gde.2013.02.012"},{"key":"2026010417165218900_R22","doi-asserted-by":"crossref","unstructured":"Hsich G, Kenney K, Gibbs CJ, et al. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. New Engl J Med. 1996;335(13):924\u201330. Epub 1996 Sep 26. CrossRef | PubMed","DOI":"10.1056\/NEJM199609263351303"},{"key":"2026010417165218900_R23","doi-asserted-by":"crossref","unstructured":"Collins S, Boyd A, Fletcher A, Gonzales M, McLean CA, Byron K, et al. Creutzfeldt-Jakob disease: diagnostic utility of 14-3-3 protein immunodetection in cerebrospinal fluid. J Clin Neurosci. 2000;7(3):203\u20138. Epub 2000 Jun 02. CrossRef | PubMed","DOI":"10.1054\/jocn.1999.0193"},{"key":"2026010417165218900_R24","doi-asserted-by":"crossref","unstructured":"Atarashi R, Satoh K, Sano K, Fuse T, Yamaguchi N, Ishibashi D, et al. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med. 2011;17(2):175\u20138. Epub 2011 Feb 1. CrossRef | PubMed","DOI":"10.1038\/nm.2294"},{"key":"2026010417165218900_R25","doi-asserted-by":"crossref","unstructured":"Atarashi R, Wilham JM, Christensen L, Hughson AG, Moore RA, Johnson LM, et al. Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking. Nat Methods. 2008;5(3):211\u20132. Epub 2008 Mar 01. CrossRef | PubMed","DOI":"10.1038\/nmeth0308-211"},{"key":"2026010417165218900_R26","doi-asserted-by":"crossref","unstructured":"Stewart LA, Rydzewska LH, Keogh GF, Knight RS. Systematic review of therapeutic interventions in human prion disease. Neurology. 2008;70(15):1272\u201381. Epub 2008 Apr 09. CrossRef | PubMed","DOI":"10.1212\/01.wnl.0000308955.25760.c2"},{"key":"2026010417165218900_R27","unstructured":"Communicable Disease Network Australia. Australian Creutzfeld-Jakob disease infection control guidelines. Canberra: Department of Health and Ageing; 2013."},{"key":"2026010417165218900_R28","doi-asserted-by":"crossref","unstructured":"Alcalde-Cabero E, Almazan-Isla J, Brandel JP, Breithaupt M, Catarino J, Collins S, et al. Health professions and risk of sporadic Creutzfeldt-Jakob disease, 1965 to 2010. Euro surveill. 2012;17(15). Epub 2012 Apr 21. PubMed | Full text","DOI":"10.2807\/ese.17.15.20144-en"},{"key":"2026010417165218900_R29","doi-asserted-by":"crossref","unstructured":"Koehler A, Athan, E, Collins, SJ. Updated Creutzfeld-Jakob disease infection control guidelines: sifting facts from fiction. Med J Australia. 2013;198(5):245. CrossRef | PubMed","DOI":"10.5694\/mja13.10114"}],"container-title":["Public Health Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/connectsci.au\/pu\/article-pdf\/doi\/10.17061\/phrp2511409\/1836494\/pu19009.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/connectsci.au\/pu\/article-pdf\/doi\/10.17061\/phrp2511409\/1836494\/pu19009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T22:16:59Z","timestamp":1767565019000},"score":1,"resource":{"primary":{"URL":"https:\/\/connectsci.au\/pu\/article\/25\/1\/e2511409\/267836\/An-update-on-the-epidemiology-and-key-issues"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,28]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,11,28]]}},"URL":"https:\/\/doi.org\/10.17061\/phrp2511409","relation":{},"ISSN":["2204-2091"],"issn-type":[{"type":"electronic","value":"2204-2091"}],"subject":[],"published":{"date-parts":[[2014,11,28]]},"article-number":"e2511409"}}